CRBP Corbus Pharmaceuticals Holdings

6.60
-0.3  -4.35%
Previous Close 6.90
Open 6.95
Price To book 22.77
Market Cap 293.28M
Shares 44,437,000
Volume 602,908
Short Ratio 7.31
Av. Daily Volume 1,156,200

SEC filingsSee all SEC filings

  1. 424B5 - Prospectus [Rule 424(b)(5)] 162017252
  2. 8-K - Current report 162017211
  3. 8-K - Current report 161990785
  4. 10-Q - Quarterly report [Sections 13 or 15(d)] 161988635
  5. 8-K - Current report 161988292

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data due 1Q 2017.
Resunab
Cystic Fibrosis
Phase 2 trial to be initiated 1H 2017.
Resunab
Systemic lupus erythematosus (SLE)
Phase 2 data due 3Q 2017.
Resunab
Dermatomyositis
Phase 2 data released November 14, 2016.
Resunab
Systemic Sclerosis

Latest News

  1. Corbus Pharmaceuticals Holdings, Inc. – Value Analysis (NASDAQ:CRBP) : January 18, 2017
  2. ETFs with exposure to Corbus Pharmaceuticals Holdings, Inc. : January 17, 2017
  3. Why Corbus Pharmaceuticals Holdings, Inc. Stock Rocketed 412% Upwards in 2016
  4. Corbus Pharmaceuticals Receives Orphan Designation for JBT-101 for the Treatment of Systemic Sclerosis in the European Union
  5. Donald Trump On Weed Legalization: What’s In Store For Marijuana Stocks?
  6. The 10 Best Stocks in the Nasdaq in 2016
  7. Here's How Big the Opportunity Could Be for Marijuana Stocks
  8. Corbus Pharmaceuticals Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CRBP-US : January 13, 2017
  9. ETFs with exposure to Corbus Pharmaceuticals Holdings, Inc. : January 4, 2017
  10. Corbus Concludes Phase II study of Cystic Fibrosis Candidate
  11. Corbus Pharmaceuticals Announces Completion of Phase 2 Study of JBT-101 (Resunab) for the Treatment of Cystic Fibrosis
  12. Corbus Pharmaceuticals Looks to Be a Winner, While Pershing Gold Requires Patience
  13. Here Are 4 Somewhat Risky Stocks That May Deliver Explosive Gains
  14. ETFs with exposure to Corbus Pharmaceuticals Holdings, Inc. : December 21, 2016
  15. As Dow heads to 20,000, here are the 20 top-gaining Mass. stocks this year
  16. Glu Mobile Inc. (GLUU): Hedge Fund Sentiment Unchanged
  17. What Happened to Marijuana Stocks in 2016?
  18. ETFs with exposure to Corbus Pharmaceuticals Holdings, Inc. : December 8, 2016
  19. Top Marijuana Stocks to Buy in 2017
  20. Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) to Ring The Nasdaq Stock Market Closing Bell

SEC Filings

  1. 424B5 - Prospectus [Rule 424(b)(5)] 162017252
  2. 8-K - Current report 162017211
  3. 8-K - Current report 161990785
  4. 10-Q - Quarterly report [Sections 13 or 15(d)] 161988635
  5. 8-K - Current report 161988292
  6. 8-K - Current report 161928426
  7. SC 13G - Statement of acquisition of beneficial ownership by individuals 161910310
  8. 8-K - Current report 161894959
  9. EFFECT - Notice of Effectiveness 161884088
  10. POS AM - Post-Effective amendments for registration statement 161876470